KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $19,000 | +35.7% | 5,600 | +41.7% | 0.00% | – |
| Q2 2018 | $14,000 | -65.9% | 3,953 | -44.0% | 0.00% | -100.0% |
| Q4 2016 | $41,000 | -73.2% | 7,057 | -75.6% | 0.00% | -80.0% |
| Q3 2016 | $153,000 | +12.5% | 28,898 | +40.6% | 0.01% | +11.1% |
| Q2 2016 | $136,000 | +248.7% | 20,554 | +144.7% | 0.01% | +200.0% |
| Q1 2016 | $39,000 | +18.2% | 8,398 | +27.3% | 0.00% | 0.0% |
| Q4 2015 | $33,000 | +83.3% | 6,598 | +249.5% | 0.00% | +50.0% |
| Q2 2015 | $18,000 | +157.1% | 1,888 | +213.1% | 0.00% | +100.0% |
| Q1 2015 | $7,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
| Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
| 1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
| Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
| FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
| OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
| Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
| Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
| THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |